The Safety of Radiofrequency Ablation Using a Novel Temperature-Controlled Probe for the Treatment of Residual Intraductal Lesions after Endoscopic Papillectomy
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background/Aims: Treatment of residual intraductal lesions after endoscopic papillectomy for ampullary adenomas is relatively difficult. Few studies have been conducted using intraductal radiofrequency ablation (RFA) in the treatment of such lesions, and no study has aimed to reduce the side effects of excessive heat caused by RFA. Recently, a temperature-controlled RFA probe was developed to avoid excessive heat. This study aimed to investigate the safety of this new RFA probe in the treatment of intraductal lesions of ampullary adenoma. Methods: Patients who received RFA for residual intraductal lesions after endoscopic papillectomy between November 2017 and June 2019 were retrospectively reviewed. A novel temperature- controlled probe (ELRA) was used for intraductal RFA, and clinical data including adverse events were collected. Results: Ten patients were included in this study. Intraductal adenomas showed low-grade dysplasia in eight patients and high-grade dysplasia in two patients. The median diameter of intraductal adenomas was 9 mm (range, 5 to 10 mm) in the common bile duct and 5 mm (range, 4 to 11 mm) in the pancreatic duct. Adverse events occurred in three patients (30.0%), of which two were mild pancreatitis and one was asymptomatic biliary stricture. Over a median follow-up period of 253 days, only one patient underwent additional surgery, as the remainder showed no adenomatous lesions on follow-up biopsies. Conclusions: The new temperature-controlled RFA probe can be used with acceptable safety for the treatment of residual intraductal lesions after endoscopic papillectomy. Further evaluation through future prospective studies is needed.
Abstract
Background/Aims: Treatment of residual intraductal lesions after endoscopic papillectomy for ampullary adenomas is relatively difficult. Few studies have been conducted using intraductal radiofrequency ablation (RFA) in the treatment of such lesions, and no study has aimed to reduce the side effects of excessive heat caused by RFA. Recently, a temperature-controlled RFA probe was developed to avoid excessive heat. This study aimed to investigate the safety of this new RFA probe in the treatment of intraductal lesions of ampullary adenoma. Methods: Patients who received RFA for residual intraductal lesions after endoscopic papillectomy between November 2017 and June 2019 were retrospectively reviewed. A novel temperature- controlled probe (ELRA) was used for intraductal RFA, and clinical data including adverse events were collected. Results: Ten patients were included in this study. Intraductal adenomas showed low-grade dysplasia in eight patients and high-grade dysplasia in two patients. The median diameter of intraductal adenomas was 9 mm (range, 5 to 10 mm) in the common bile duct and 5 mm (range, 4 to 11 mm) in the pancreatic duct. Adverse events occurred in three patients (30.0%), of which two were mild pancreatitis and one was asymptomatic biliary stricture. Over a median follow-up period of 253 days, only one patient underwent additional surgery, as the remainder showed no adenomatous lesions on follow-up biopsies. Conclusions: The new temperature-controlled RFA probe can be used with acceptable safety for the treatment of residual intraductal lesions after endoscopic papillectomy. Further evaluation through future prospective studies is needed.
참고문헌 (26)
- Chini P, "Diagnosis and management of ampullary adenoma : the expanding role of endoscopy", World J Gastrointest Endosc, 3, pp.241~247 (2011)
- Baker HL, "Lesions of the ampulla of Vater", Surgery, 21, pp.523~531 (1947)
- Stolte M, "Adenoma-carcinoma sequence in the papilla of Vater", Scand J Gastroenterol, 31, pp.376~382 (1996)
- Di Giorgio A, "Pancreatoduodenectomy for tumors of Vater’s ampulla : report on 94 consecutive patients", World J Surg, 29, pp.513~518 (2005)
- Martin JA, "Ampullary adenoma : clinical manifestations, diagnosis, and treatment", Gastrointest Endosc Clin N Am, 13, pp.649~669 (2003)
- Farnell MB, "Villous tumors of the duodenum : reappraisal of local vs. extended resection", J Gastrointest Surg, 4, pp.13~21 (2000)
- Bohnacker S, "Endoscopic resection of benign tumors of the duodenal papilla without and with intraductal growth", Gastrointest Endosc, 62, pp.551~560 (2005)
- Rustagi T, "Radiofrequency ablation for intraductal extension of ampullary neoplasms", Gastrointest Endosc, 86, pp.170~176 (2017)
- Larghi A, "Endoscopic radiofrequency biliary ablation treatment : a comprehensive review", Dig Endosc, 31, pp.245~255 (2019)
- Sharaiha RZ, "Impact of radiofrequency ablation on malignant biliary strictures : results of a collaborative registry", Dig Dis Sci, 60, pp.2164~2169 (2015)
- Yang J, "Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma : a randomized trial", Endoscopy, 50, pp.751~760 (2018)
- Camus M, "Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy : a multicenter prospective study", Gastrointest Endosc, 88, pp.511~518 (2018)
- Cho JH, "Safety and effectiveness of endobiliary radiofrequency ablation according to the different power and target temperature in a swine model", J Gastroenterol Hepatol, 32, pp.521~526 (2017)
- Lee YN, "The safety of newly developed automatic temperature-controlled endobiliary radiofrequency ablation system for malignant biliary strictures : a prospective multicenter study", J Gastroenterol Hepatol, 34, pp.1454~1459 (2019)
- Cotton PB, "A lexicon for endoscopic adverse events: report of an ASGE workshop", Gastro-intest Endosc, 71, pp.446~454 (2010)
- Han J, "Endoscopic papillectomy for adenomas of the major duodenal papilla(with video)", Gastrointest Endosc, 63, pp.292~301 (2006)
- Nam K, "Usefulness of argon plasma coagulation ablation subsequent to endoscopic snare papillectomy for ampullary adenoma", Dig Endosc, 30, pp.485~492 (2018)
- ASGE Standards of Practice Committee, "The role of endoscopy in ampullary and duodenal adenomas", Gastrointest Endosc, 82, pp.773~781 (2015)
- Kim YS, "Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma : analysis of prognostic factors", J Hepatol, 58, pp.89~97 (2013)
- Shah DR, "Current oncologic applications of radiofrequency ablation therapies", World J Gastrointest Oncol, 5, pp.71~80 (2013)
- Sofi AA, "Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures : a systematic review and meta-analysis", Gastrointest Endosc, 87, pp.944~951 (2018)
- Mehendiratta V, "Use of radiofrequency ablation probe for eradication of residual adenoma after ampullectomy", Gastrointest Endosc, 81, pp.1055~1056 (2015)
- Valente R, "ERCP-directed radiofrequency ablation of ampullary adenomas : a knifesparing alternative in patients unfit for surgery", Endoscopy, 47(Suppl 1 UCTN), pp.E515~E516 (2015)
- Zheng X, "Endoscopic radiofrequency ablation may be preferable in the management of malignant biliary obstruction : a systematic review and meta-analysis", J Dig Dis, 17, pp.716~724 (2016)
- Cho JH, "Longterm results of temperature-controlled endobiliary radiofrequency ablation in a normal swine model", Gastrointest Endosc, 87, pp.1147~1150 (2018)
- Borne RT, "Longer duration versus increasing power during radiofrequency ablation yields different ablation lesion characteristics", JACC Clin Electrophysiol, 4, pp.902~908 (2018)